JAMA Ophthalmology : Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab
- Author
- American Medical Association, 2017
- Published
- Thu 06 Mar 2025
- Episode Link
- https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jamaophthalmol.2025.511
Interview with Arshad M. Khanani, MD, author of Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial. Hosted by Neil Bressler, MD.
Related Content:
